लोड हो रहा है...
Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis
This case illustrates a 36-year-old man who presented with a factor VIII (FVIII) inhibitor (acquired haemophilia A) with cutaneous bleeding and a significant thigh haematoma. No traditional risk factors for the development of a FVIII inhibitor were identified. However, previous treatment with alemtu...
में बचाया:
| में प्रकाशित: | BMJ Case Rep |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMJ Publishing Group
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254386/ https://ncbi.nlm.nih.gov/pubmed/30337289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226588 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|